Endpoints News
Musculoskeletal startup raises $130M Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M T W Thu F
5 February, 2026
Cell & Gene Day 2026
CGT has fresh momentum from new FDA frameworks and pharma deals, but do the latest advances in science, manufacturing, and regulation actually solve the core challenges? We’re asking the hard questions — join us.
presented by Clinical Enrollment & Predoc
Biggest SCOPE Buzz: Two Dis­rup­tors in Clin­i­cal Re­search Are Re­defin­ing En­roll­ment Speed
news
Flagship’s Generate files for an IPO in key test for the AI bio field
ENDPOINTS NEWS
Angitia gets $130M Series D for pipeline of musculoskeletal drugs
ENDPOINTS NEWS
AbbVie says immunology blockbusters will be 'main drivers' of growth post-Humira 
ENDPOINTS NEWS
endpoints pharma
Rare pediatric PRV program reauthorized until 2029 via government funding law
ENDPOINTS NEWS
FTC settles insulin suit with Express Scripts, with wider implications attached
ENDPOINTS NEWS
UK’s health department expected to spend £1B in pharma trade deal with US
ENDPOINTS NEWS
Hims adds Grail's cancer test amid questions about widespread use
ENDPOINTS NEWS
in case you missed it
1.
GSK’s new CEO eyes more dealmaking, intense pipeline inspection
ENDPOINTS NEWS
2.
Updated: Embattled Novo Nordisk considers buying a monthly GLP-1, unveils pipeline cuts
ENDPOINTS NEWS
3.
Updated: Novartis expects generics to shave $4B from 2026 sales, as Entresto takes Q4 hit
ENDPOINTS NEWS
4.
Lilly beats sales forecasts, plots major growth in 2026 in stark contrast to Novo
ENDPOINTS NEWS
5.
Veradermics lands upsized $256M IPO in sign of demand for oral Rogaine — and biotech listings
ENDPOINTS NEWS
6.
Amgen says it doesn’t plan to pull its rare disease drug Tavneos, despite FDA ask
ENDPOINTS NEWS
7.
Innovative CAR-T therapy destroys cancer cells without dangerous side effects
NATURE
8.
Novo reports first Ozempic sales drop in greater China region
REUTERS
Reynald Castaneda
.

Our weekly manufacturing newsletter comes out today at 1 p.m. ET. If you’re not subscribed yet, you can sign up here.

.
Reynald Castaneda
Deputy Editor, Endpoints News
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.